| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 04/24/2003 | WO2003033479A1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 04/24/2003 | WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | US20030078434 An aromatic sulfonamide compound for treating glomerulonephritis and diabetic nephropathy, having a superior antiproteinuric effect and superior inhibitory activity for type IV collagenase |
| 04/24/2003 | US20030078239 Ketone compounds and compositions for cholesterol management and related uses |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/23/2003 | EP1303499A1 Tetrazole derivatives |
| 04/23/2003 | EP0904264B1 Compositions for increasing the mri contrast in visualising the digestive tract of patients |
| 04/23/2003 | EP0889881B1 New triazoles as therapeutic agents for fungal infections |
| 04/22/2003 | US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2001053275A3 Substituted aryl ketones |
| 04/17/2003 | US20030073839 Compounds useful for preparation of Beta-3 adrenoreceptor agonist |
| 04/17/2003 | US20030072715 Cyclic polyamine compounds for cancer therapy |
| 04/17/2003 | DE10135356C1 Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen Macrocyclic metal complexes and their use for the preparation of conjugates with biomolecules |
| 04/16/2003 | EP1302465A1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 04/16/2003 | EP1301492A1 Novel tetrazole derivatives |
| 04/16/2003 | EP1301474A2 Tyrosine derivatives as phosphatase inhibitors |
| 04/16/2003 | EP0972769B1 Novel amide derivatives and medicinal compositions thereof |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548525 Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors |
| 04/15/2003 | US6548512 Nitrogen containing heteroaromatics as factor Xa inhibitors |
| 04/15/2003 | US6548450 Tetrazolinone derivatives |
| 04/10/2003 | WO2003029229A1 Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method |
| 04/10/2003 | WO2003029228A1 Novel method of preparing nitrogen macrocycles |
| 04/10/2003 | US20030069284 Anticancer agent |
| 04/10/2003 | US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/10/2003 | CA2461344A1 Novel method of preparing nitrogen macrocycles |
| 04/09/2003 | EP0768898B1 Cascade-polymer complexes and methods of producing the same |
| 04/08/2003 | US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 04/08/2003 | US6545054 Alkenyl and alkynyl compounds as inhibitors of factor Xa |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/03/2003 | WO2003027632A2 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | WO2003027082A1 Preparation of bis-(1(2)h-tetrazol-5-yl)-amine monohydrate |
| 04/03/2003 | WO2003027081A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 04/03/2003 | WO2003026668A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 04/03/2003 | WO2003026638A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/03/2003 | US20030065031 Glucagon antagonists/inverse agonists |
| 04/03/2003 | CA2461532A1 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/03/2003 | CA2460541A1 Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer |
| 04/03/2003 | CA2455989A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/03/2003 | CA2455910A1 Ophthalmologic treatment methods using selective inos inhibitors |
| 04/02/2003 | EP1296942A1 Glucagon antagonists/inverse agonists |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024922A1 Hydroxyfattysulfonic acid analogs |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
| 03/27/2003 | WO2003024390A2 Hydroxyeicosenoic acid analogs |
| 03/27/2003 | US20030060634 Reacting sodium dicyanamide, sodium azide, and water, then treating with hydrochloric acid |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2460358A1 Hydroxyfattysulfonic acid analogs |
| 03/27/2003 | CA2460263A1 Hydroxyeicosenoic acid analogs |
| 03/26/2003 | EP1296142A2 Calcium receptor active molecules |
| 03/26/2003 | EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 03/26/2003 | EP1294378A2 Thrombopoietin mimetics |
| 03/20/2003 | WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 03/20/2003 | US20030055038 For therapy of central nervous system and other disorders |
| 03/19/2003 | EP1292283A1 A medicinal aerosol formulation |
| 03/13/2003 | WO2002072506A3 7-pyrollyl tetracycline compounds and methods of use thereof |
| 03/12/2003 | EP1289969A1 Substituted n-benzoyl-n'-(tetrazolylphenyl)-ureas and their use as pest control agents |
| 03/12/2003 | EP1289941A1 Carbamic acid esters as inhibitors of factor xa |
| 03/12/2003 | EP1289935A1 Excitatory amino acid receptor modulators |
| 03/12/2003 | EP1289571A2 Prochelators of radiometal labeled molecules |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | EP0670835B1 Process for preparing benzopyran compounds |
| 03/11/2003 | CA2041620C An ortho-lithiation process for the synthesis of 2-substituted-1-(tetrazol-5-yl) benzenes |
| 03/06/2003 | WO2003018008A1 Apo ai expression accelerating agent |
| 03/06/2003 | WO2002094770A3 Aminoalcohol derivatives |
| 03/05/2003 | EP1288199A1 Mmp-12 inhibitors |
| 03/05/2003 | EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1183255B1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/04/2003 | US6528627 Bridged aromatic substituted amine ligands with donor atoms |
| 03/04/2003 | US6528499 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| 02/27/2003 | WO2003016303A1 Tetrazoyl oxime derivative and agricultural chemical containing the same as active ingredient |
| 02/27/2003 | WO2003016290A1 Process for preparation of tetrazolinone compounds |
| 02/27/2003 | WO2003016270A2 Selective estrogen receptor modulators |
| 02/27/2003 | US20030040535 Tetrazole compounds as thyroid receptor ligands |
| 02/26/2003 | EP1285917A1 Process for producing carbostyril derivative |
| 02/26/2003 | EP1284961A1 Glycinamides |
| 02/26/2003 | EP0938483B1 Muscarinic antagonists |
| 02/26/2003 | EP0923635B1 Metal ligand containing bleaching compositions |
| 02/26/2003 | EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals |
| 02/25/2003 | US6525203 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/25/2003 | US6525099 N-substituted sulfonamide derivatives |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525020 For drug delivery |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1101817C Process for prepn. of tetrazamacrocycles |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |